This report analyzes the impact of environmental pressures on the Healthcare Sector.
Climate change and related themes (including heatwaves, emissions, deforestation, and water shortages) continued to remain in the spotlight in 2022. Financial institutions, businesses, and governments have increased their efforts to align with UN SDGs. We expect this trend to continue in 2023.
Climate change and related themes (including heatwaves, emissions, deforestation, and water shortages) continued to remain in the spotlight in 2022. Financial institutions, businesses, and governments have increased their efforts to align with UN SDGs. We expect this trend to continue in 2023.
Who Should Buy
Senior executives and ESG executives in Healthcare industry.Scope
- This report provides an overview of world's climate in 2030. It focuses on the assessment of impact of environmental pressures on the Healthcare sector.
Reasons to Buy
- The world is moving fast toward an environmental disaster. Governments have been distracted by pandemics, wars, and rising inflation. But consumers - especially young consumers - continue to maintain pressure on businesses to act. CEOs that are too slow to improve their company's approach to sustainability will see an exodus of customers and a drop in profits far sooner than they ever imagined. Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. ESG is one of the most important themes for 2023.
Table of Contents
- What will the world's climate be like in 2030?
- What's trending on social media?
- How are reporting and disclosure requirements changing?
- Who's innovating in environmental technology?
- Assessing the impact of environmental pressures in healthcare
- Appendices
2. Glossary
3. ESG framework environmental factors
4. Thematic Intelligence methodology
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca
- Philips
- Kaiser Permanente
- Novartis
- Lupin
- AGC Biologics
- MSD
- Syneos Health
- Labcorp
- BD
- Puritan
- Tokio Marin
- Munich Re
- Legal and General
- Avivas
- Prudential
- WHO
- R+v
- ICF
- CDC Foundation
- Linde
- Mitsui
- TechNode
- Commonwealth Fund
- AstraZeneca
- Sanofi
- Takeda
- Pfizer
- Roche
- Merck and Co.
- Novartis
- Bristol Myers Squibb
- GSK
- Thermo Fischer Scientific
- Bayer
- Johnson and Johnson
- Amgen
- IQVIA
- Novo Nordisk
- Lilly
- Gilead Sciences
- Boehringer Sohn
- Abbvie
- Merck
- Biogen
- Astellas Pharma
- UCB
- Parexel
- Catalent
- Vertex
- Daiichi Sankyo
- Regeneron
- CSL
- Teva
- Abbott
- Medtronic
- DexCom
- Philips
- Apple
- Baxter
- Omron
- Siemens Healthineer
- Zimmer Biomet
- Stryker
- Thermo Fischer Scientific
- Becton Dickinson
- Garmin
- Nihon Kohden
- Biotronik
- 3M
- Intuitive Surgical
- Agilent Tech
- Qiagen
- Illumina
